EUVIMEDEUVIMED entdecken
Fallbericht

Lymphoid follicular hyperplasia in patients with systemic lupus erythematosus after multiple cycles of rituximab

Ingrid Ruiz-Ordóñez, Víctor A Santos, Fabio Bonilla-Abadía, Nhora Silva, Aura Sánchez, Gabriel J Tobón, Carlos A Cañas

Modern Rheumatology Case Reports · 2023

DOI: 10.1093/mrcr/rxac066 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2023. Verfasst von Ingrid Ruiz-Ordóñez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Clínicas, Fundación Valle de Lili, Cali, Colombia. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lymphadenopathy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rituximab is indicated in some patients with refractory systemic lupus erythematosus (SLE). Occasionally, this medication is required in chronic form to maintain control of the disease. We described two patients who developed lymphoid follicular hyperplasia (LFH) after multiple cycles of rituximab and evaluated the expression of B cell activating factor belonging to the tumor necrosis factor (TNF) family (BAFF) and its receptors [BAFF-receptor (BAFF-R) and B cell maturation antigen (BCMA)], as possible factors related to lymphoid node enlargement. Two patients with SLE completed six and nine cycles of rituximab (1 g every 2 weeks) indicated each 9 months, achieving remission for 5 and 7 years, respectively, when developed prominent lymphadenopathies. Biopsies showed LFH. Haematological neoplasms were ruled out. Immunohistochemistry showed BAFF overexpression in the follicles, and moderate expression of BAFF-R confined to the mantle zone and BCMA to the germinal centre. Belimumab B cell activating factor belonging to the TNF family (anti-BAFF therapy) was started with positive effects on the clinical condition. LFH can develop in patients with SLE who received multiple cycles of rituximab. BAFF overexpression and moderate expression of BAFF-R and BCMA in lymph nodes were seen. These findings added to the improvement with the change to belimumab could suggest that LFH after cluster of differentiation (CD20) depletion therapy may be associated with a compensatory overexpression of BAFF and its receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicLymphadenopathyHumansRituximabB-Cell Activating FactorHyperplasiaB-Cell Maturation Antigen

Stichwörter der Autor:innen

BAFFLymphadenopathyanti-CD20 therapylymph nodessystemic lupus erythematosus

Substanzen

RituximabB-Cell Activating FactorB-Cell Maturation Antigen

Autor:innen und Institutionen

  • Centro de Investigaciones Clínicas, Fundación Valle de Lili, Cali, Colombia.
  • Facultad de Ciencias de la Salud, Unidad de Reumatología, Universidad Icesi, Cali, Colombia.
  • Unidad de Reumatología, Fundación Valle de Lili, Cali, Colombia.
  • Departamento de Patología, Fundación Valle de Lili, Cali, Colombia.
  • Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University, Springfield, IL, USA.
  • CIRAT: Centro de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional, Universidad Icesi, Cali, Colombia.

Zitieren

APA

Ruiz-Ordóñez, I., Santos, V. A., Bonilla-Abadía, F., Silva, N., Sánchez, A., Tobón, G. J., & Cañas, C. A. (2023). Lymphoid follicular hyperplasia in patients with systemic lupus erythematosus after multiple cycles of rituximab. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxac066

Vancouver

Ruiz-Ordóñez I, Santos VA, Bonilla-Abadía F, Silva N, Sánchez A, Tobón GJ, et al. Lymphoid follicular hyperplasia in patients with systemic lupus erythematosus after multiple cycles of rituximab. Modern Rheumatology Case Reports. 2023. doi:10.1093/mrcr/rxac066

BibTeX
@article{RuizOrdez2023,
  author = {Ruiz-Ordóñez, Ingrid and Santos, Víctor A and Bonilla-Abadía, Fabio and Silva, Nhora and Sánchez, Aura and Tobón, Gabriel J and Cañas, Carlos A},
  title = {Lymphoid follicular hyperplasia in patients with systemic lupus erythematosus after multiple cycles of rituximab},
  journal = {Modern Rheumatology Case Reports},
  year = {2023},
  doi = {10.1093/mrcr/rxac066}
}
Kostenlos starten →